Biological variation and reference intervals for circulating osteopontin, osteoprotegerin, total soluble receptor activator of nuclear factor kappa B ligand and high-sensitivity C-reactive protein

被引:27
作者
Sennels, H. P.
Jacobsen, S.
Jensen, T.
Hansen, M. S.
Ostergaard, M.
Nielsen, H. J.
Sorensen, S.
机构
[1] Copenhagen Univ Hosp, Hvidovre Hosp, Dept Clin Biochem, DK-2650 Hvidovre, Denmark
[2] Copenhagen Univ Hosp, Rigshosp, Dept Rheumatol, Copenhagen, Denmark
[3] Copenhagen Univ Hosp, Hvidovre Hosp, Dept Rheumatol, Copenhagen, Denmark
[4] Copenhagen Univ Hosp, Herlev Hosp, Dept Rheumatol, Copenhagen, Denmark
[5] Copenhagen Univ Hosp, Hvidovre Hosp, Dept Surg Gastroenterol, Copenhagen, Denmark
关键词
blood donors; ELISA; inter-observer variation; intra-observer variation; quality control;
D O I
10.1080/00365510701432509
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective. Monitoring inflammatory diseases and osteoclastogenesis with osteopontin (OPN), osteoprotegerin (OPG), total soluble receptor activator of nuclear factor kappa B ligand (total sRANKL) and high-sensitivity C-reactive protein (hsCRP) has recently attracted increased interest. The purpose of our study was to determine reference intervals, variability caused by sampling time, biological variation and stability after repeated freeze-thaw cycles of circulating levels of OPN, OPG, total sRANKL and hsCRP. Material and methods. Plasma OPN and plasma OPG concentrations were determined with sandwich ELISA; serum total sRANKL concentration was determined using a two-site sandwich ELISA; and hsCRP was analysed by turbidimetry in 300 Danish blood donors (183 M and 117 F) with a median age of 43 years (range 18-64 years). Variability due to biological variation and sampling time was studied in serial samples from 38 healthy subjects. Results. The 95th percentiles in the donors were 76 mu g/L for OPN, 4.2 pmol/L for OPG, 40.2 nmol/L for total sRANKL and 12 mu g/L for hsCRP. The overall medians for both genders were 51 mu g/L, 2.2 pmol/L, 0.66 nmol/L and 1.0 mg/L, respectively. We found a significant correlation between hsCRP and OPN ( rho50.173; p<0.003). The biological within-subject variations were calculated to be 8.2 % for OPN, 8.8 % for total sRANKL and 50 % for hsCRP. Conclusions. Reference intervals have been established with a high analytic performance for OPN and an acceptable analytic performance for OPG and total sRANKL. The study revealed low biological variation for OPN and total sRANKL and high biological variation for hsCRP.
引用
收藏
页码:821 / 835
页数:15
相关论文
共 49 条
[1]   Eta-1 (osteopontin): An early component of type-1 (cell-mediated) immunity [J].
Ashkar, S ;
Weber, GF ;
Panoutsakopoulou, V ;
Sanchirico, ME ;
Jansson, M ;
Zawaideh, S ;
Rittling, SR ;
Denhardt, DT ;
Glimcher, MJ ;
Cantor, H .
SCIENCE, 2000, 287 (5454) :860-864
[2]   C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites [J].
Chambers, JC ;
Eda, S ;
Bassett, P ;
Karim, Y ;
Thompson, SG ;
Gallimore, JR ;
Pepys, MB ;
Kooner, JS .
CIRCULATION, 2001, 104 (02) :145-150
[3]   Effect of anticoagulants and storage temperature on the stability of receptor activator for nuclear factor-κB ligand and osteoprotegerin in plasma and serum [J].
Chan, BYY ;
Buckley, KA ;
Durham, BH ;
Gallagher, JA ;
Fraser, WD .
CLINICAL CHEMISTRY, 2003, 49 (12) :2083-2085
[4]   Stereoselective pharmacokinetics of propafenone and its major metabolites in healthy Chinese volunteers [J].
Chen, XY ;
Zhong, DF ;
Blume, H .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 10 (01) :11-16
[5]   BIOLOGICAL VARIATION OF ACUTE-PHASE PROTEINS [J].
CLARK, GH ;
FRASER, CG .
ANNALS OF CLINICAL BIOCHEMISTRY, 1993, 30 :373-376
[6]   Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin [J].
Collin-Osdoby, P .
CIRCULATION RESEARCH, 2004, 95 (11) :1046-1057
[7]   Plasma osteopontin levels in multiple sclerosis [J].
Comabella, M ;
Pericot, I ;
Goertsches, R ;
Nos, C ;
Castillo, M ;
Navarro, JB ;
Río, J ;
Montalban, X .
JOURNAL OF NEUROIMMUNOLOGY, 2005, 158 (1-2) :231-239
[8]  
Erlandsen EJ, 2000, SCAND J CLIN LAB INV, V60, P37
[9]   Need for correct estimates of biological variation: The example of C-reactive protein [J].
Franzini, C .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 1998, 36 (02) :131-132
[10]  
FRASER CG, 1989, CRIT REV CL LAB SCI, V27, P409